FDA rollback of mandatory drug monitoring

A child psychiatrist counts four academic centers and no clozapine prescriber

In February 2025 the FDA scrapped the blood-monitoring registry that governed clozapine for three decades. A psychiatrist who prescribes it to children says the paperwork was never the binding constraint. The number that would test that claim is missing.